UPB 8-K 2026-09-01

Upstream Bio, Inc. (UPB) 8-K dated 2026-09-01 — accession 0001193125-26-377485. This URL is the filing, not the UPB hub.

Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.

Upstream Bio, Inc. filed a 8-K on 2026-09-01. Accession 0001193125-26-377485.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.

Not investment advice. The UPB SEC hub lists recent forms. The stock page is the research view.